APPEAL: a toolkit for attracting people who inject drugs with hepatitis C to healthcare systems

被引:0
|
作者
Baptista-Leite, Ricardo [1 ,2 ]
Lopes, Henrique [1 ]
Franco, Diogo [1 ]
Clemens, Timo [2 ]
Brand, Helmut [2 ]
机构
[1] Univ Nova Lisboa, NOVA Ctr Global Hlth, NOVA IMS, Lisbon, Portugal
[2] Maastricht Univ, CAPHRI, Dept Int Hlth, Fac Hlth Med & Life Sci, Maastricht, Netherlands
来源
JOURNAL OF PUBLIC HEALTH-HEIDELBERG | 2024年
基金
英国科研创新办公室;
关键词
Public health; People who inject drugs (PWID); Hepatitis C; Vulnerable groups; Care cascade; Service quality improvement; DISEASE; VIRUS; RISK; HIV; HCV;
D O I
10.1007/s10389-024-02276-1
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Aim The "APPEAL" toolkit was developed to address the challenges in diagnosing people who inject drugs (PWID) with hepatitis C (HCV) and engaging them with healthcare systems. It introduces an ecosystemic approach based on health and well-being literacy across awareness, prevention and diagnosis dimensions of the hepatitis C's care cascade (CC) for PWID.Subject and methods The framework incorporated a scoping review and thematic analysis of 54 studies, alongside contributions from 57 hepatitis C key opinion leaders across seven countries. The toolkit is structured around five main axes: problems, solutions, outputs, outcomes and feedback process, employing a holistic perspective that considers economic, legal and social contexts. Eighteen policy prescriptions (PP) are proposed and supported by selective references to ensure relevance and applicability.Results The APPEAL toolkit facilitates a strategic workflow for policymakers, health authorities and patient advocacy organizations, guiding them through action flowcharts to evaluate and enhance their interventions within the hepatitis C's CC for PWID. Notably, its implementation demonstrated potential in identifying and attracting PWID to hepatitis C treatment pathways, contributing to increased diagnostics, education on risk behaviours and raising overall disease awareness. The toolkit's intelligent cycle system supports accountability, enabling continuous data-driven improvement and innovation in addressing hepatitis C.Conclusion The APPEAL toolkit was developed to attract PWID living with HCV to healthcare systems in a proactive manner. By managing information and fostering education on HCV, it aims to amplify awareness, prevention and diagnosis. The toolkit's design and functionality underscore the importance of continuous quality improvement and the potential for its use in internal or external quality audits of healthcare services related to hepatitis C.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs
    Robaeys, Geert
    Grebely, Jason
    Mauss, Stefan
    Bruggmann, Philip
    Moussalli, Joseph
    De Gottardi, Andrea
    Swan, Tracy
    Arain, Amber
    Kautz, Achim
    Stoever, Heino
    Wedemeyer, Heiner
    Schaefer, Martin
    Taylor, Lynn
    Backmund, Markus
    Dalgard, Olav
    Prins, Maria
    Dore, Gregory J.
    CLINICAL INFECTIOUS DISEASES, 2013, 57 : S129 - S137
  • [22] A new challenge for the Mexican health system: hepatitis C in people who inject drugs
    Magis-Rodriguez, Carlos
    Marin-Navarrete, Rodrigo
    Garcia-Juarez, Ignacio
    SALUD MENTAL, 2019, 42 (04) : 147 - 148
  • [23] Recommendations for the management of hepatitis C virus infection among people who inject drugs
    Grebely, Jason
    Robaeys, Geert
    Bruggmann, Philip
    Aghemo, Alessio
    Backmund, Markus
    Bruneau, Julie
    Byrne, Jude
    Dalgard, Olav
    Feld, Jordan J.
    Hellard, Margaret
    Hickman, Matthew
    Kautz, Achim
    Litwin, Alain
    Lloyd, Andrew R.
    Mauss, Stefan
    Prins, Maria
    Swan, Tracy
    Schaefer, Martin
    Taylor, Lynn E.
    Dore, Gregory J.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2015, 26 (10) : 1028 - 1038
  • [24] Candidate hepatitis C vaccine trials and people who inject drugs: Challenges and opportunities
    Maher, Lisa
    White, Bethany
    Hellard, Margaret
    Madden, Annie
    Prins, Maria
    Kerr, Thomas
    Page, Kimberly
    VACCINE, 2010, 28 (45) : 7273 - 7278
  • [25] Hepatitis C Care Cascades for 3 Populations at High Risk: Low-income Trans Women, Young People Who Inject Drugs, and Men Who Have Sex With Men and Inject Drugs
    Facente, Shelley N.
    Patel, Sheena
    Hecht, Jennifer
    Wilson, Erin
    McFarland, Willi
    Page, Kimberly
    Vickerman, Peter
    Fraser, Hannah
    Burk, Katie
    Morris, Meghan D.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (06) : E1290 - E1295
  • [26] Hepatitis C cascade of care at an integrated community facility for people who inject drugs
    Morris, Leith
    Selvey, Linda
    Williams, Owain
    Gilks, Charles
    Kvassy, Amanda
    Smirnov, Andrew
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2020, 114
  • [27] Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews
    Nelson, Paul K.
    Mathers, Bradley M.
    Cowie, Benjamin
    Hagan, Holly
    Des Jarlais, Don
    Horyniak, Danielle
    Degenhardt, Louisa
    LANCET, 2011, 378 (9791) : 571 - 583
  • [28] HIV, Hepatitis B and C among people who inject drugs: high prevalence of HIV and Hepatitis C RNA positive infections observed in Delhi, India
    Saraswati, Lopamudra Ray
    Sarna, Avina
    Sebastian, Mary Philip
    Sharma, Vartika
    Madan, Ira
    Thior, Ibou
    Pulerwitz, Julie
    Tun, Waimar
    BMC PUBLIC HEALTH, 2015, 15
  • [29] Injecting frequency trajectories and hepatitis C virus acquisition: Findings from a cohort of people who inject drugs in Montreal, Canada
    Fortier, Emmanuel
    Hoj, Stine Bordier
    Sylvestre, Marie-Pierre
    Artenie, Andreea Adelina
    Minoyan, Nanor
    Jutras-Aswad, Didier
    Grebely, Jason
    Bruneau, Julie
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2021, 96
  • [30] High burden of hepatitis C & HIV co-infection among people who inject drugs in Manipur, Northeast India
    Kermode, Michelle
    Nuken, Amenla
    Medhi, Gajendra Kumar
    Akoijam, Brogen Singh
    Sharma, H. Umesh
    Mahanta, Jagadish
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2016, 143 : 348 - 356